Combinational therapy with metformin and sodium-glucose cotransporter inhibitors in management of type 2 diabetes: systematic review and meta-analyses.
Published Sep 1, 2014 · Qian Zhang, J. Dou, Ju‐ming Lu
Diabetes research and clinical practice
39
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawaySGLT-2 inhibitors combined with metformin show potential in improving glycemic control, body weight, and blood pressure in type 2 diabetes patients, but further trials are needed to confirm this evidence.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.